Autophagic Signatures in Health and Disease: Molecular Insights and Clinical Applications

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Autophagy".

Deadline for manuscript submissions: 20 February 2026 | Viewed by 4

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical Sciences, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, 44121 Ferrara, Italy
Interests: autophagy; mitophagy; neurodegeneration; cancer; mitochondria; calcium; endoplasmic reticulum; apoptosis; chemotherapy; mitochondrial diseases
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy
Interests: autophagy; calcium; mitochondrial disorders; cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Autophagy is a tightly regulated and evolutionarily conserved catabolic process essential to cellular quality control and adaptation to stress. Originally considered a general mechanism for the bulk degradation of cytoplasmic components, it is now clear that autophagy encompasses a range of highly specialized forms—including mitophagy, lipophagy, xenophagy, chaperone-mediated autophagy (CMA), and ER-phagy—with each tailored to selectively target specific intracellular substrates.

These selective autophagy pathways are not only crucial in maintaining cellular and tissue homeostasis, they are also emerging as key players in a wide range of diseases, including cancer, neurodegeneration, metabolic disorders, infections, and immune dysregulation. Recent advances have uncovered compelling evidence linking the autophagic machinery to clinically relevant processes, opening up possibilities for their use as a source of novel diagnostic and prognostic biomarkers, as well as predictive indicators for therapeutic responses.

In particular, understanding how specific autophagy-related proteins correlate with established clinical biomarkers can lead to exciting opportunities to enhance diagnostic accuracy, stratify patients, and monitor disease progression or therapeutic efficacy. This is especially relevant in the context of precision medicine, where the integration of autophagy-based indicators may help refine treatment strategies.

The aim of this Special Issue is to provide a comprehensive overview of the multifaceted roles of autophagy in health and disease, with a particular focus on the following areas:

  • The mechanisms and regulation of selective autophagy (e.g., mitophagy, lipophagy, xenophagy, CMA, ER-phagy);
  • Autophagy as a source of diagnostic, prognostic, and predictive disease biomarkers;
  • The correlation between autophagic pathways and approved clinical biomarkers;
  • The interplay between autophagy and key signaling networks (e.g., inflammation, immunity, metabolism);
  • The role of autophagy in tissue homeostasis, cellular stress, and pathogenesis;
  • Novel therapeutic strategies targeting autophagy-related pathways;
  • Innovative technologies to monitor autophagic flux and specificity in clinical and experimental settings.

We encourage the submission of original research articles, comprehensive reviews, and methodological papers that address these topics and can contribute to expanding our current understanding of autophagy in translational and clinical contexts.

We look forward to receiving your valuable contributions.

Dr. Simone Patergnani
Dr. Alberto Danese
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • autophagy
  • pathology
  • physiology
  • therapy
  • methods

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop